The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms

By sjmartinez • March 25, 2025

Solomon DH, Paudel M, Chitineni S, Fernandes A, Pham T, Billa S, Yokose C, Tan K, Dedier JJ, Dubreuil MD, Fitzgerald JD, Hodder SL, Neogi T, Pillinger MH, Riggs KR, Saag KG, Shekelle PG, Tseng Z, Toprover M, Wei DS, Barry MJ, Choi HK. The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms. ACR Open Rheumatol. 2025 Mar;7(3):e70012. doi: 10.1002/acr2.70012. PMID: 40126890.

Tags: General Internal Medicine, Publications, Rheumatology, Veterans Administration

Implementing a Cardiology Quality Incentive Program to Improve Guideline-Directed Medical Therapy

Cho DJ, Bokhoor PI, Dermenchyan A, Brownell N, Delavin NL, Furlong S, Hoo J, Tibbe T, Chen LY, Vangala S, Waterman BA, Han M, Fonarow[...]

Takotsubo Cardiomyopathy Due to Diffuse Large B-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis

Kim JS, Ai A, Melamed KH. Takotsubo Cardiomyopathy Due to Diffuse Large B-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis. JACC Case Rep. 2025 Jun 18;30(15):103691. doi: 10.1016/j.jaccas.2025.103691. PMID:[...]

How Participatory Research Can Inform Antiracism Approaches to Advance Kidney Health Equity

Senghor AS, Okoye G, Ford CL, Crews DC, Norris KC. How Participatory Research Can Inform Antiracism Approaches to Advance Kidney Health Equity. J Am Soc[...]